Selected article for: "specific tumor type and tumor type"

Author: Xiao Huang; Jasper Z. Williams; Ryan Chang; Zhongbo Li; Eric Gai; David M. Patterson; Yu Wei; Wendell A. Lim; Tejal A. Desai
Title: DNA-scaffolded biomaterials enable modular and tunable control of cell-based cancer immunotherapies
  • Document date: 2019_3_23
  • ID: 5bw7umap_50
    Snippet: We believe that the true promise of the AICE platform will be realized by using particles to present multiple signals within the tumor microenvironment. AICE particles could kick-start tumor killing by triggering CAR expression by synNotch-CAR T cells. T cell activity within the tumor could be further augmented by cofunctionalization of AICE particles with additional cargos that go beyond a synNotch ligand, for instance, a costimulatory ligand an.....
    Document: We believe that the true promise of the AICE platform will be realized by using particles to present multiple signals within the tumor microenvironment. AICE particles could kick-start tumor killing by triggering CAR expression by synNotch-CAR T cells. T cell activity within the tumor could be further augmented by cofunctionalization of AICE particles with additional cargos that go beyond a synNotch ligand, for instance, a costimulatory ligand and a checkpoint inhibitor tailored to circumvent the specific immune evasion mechanisms of a particular tumor type 17, 45 .

    Search related documents:
    Co phrase search for related documents
    • car expression and tumor killing: 1
    • cell activity and checkpoint inhibitor: 1
    • cell activity and immune evasion: 1, 2, 3, 4, 5, 6, 7
    • cell activity and immune evasion mechanism: 1
    • cell activity and multiple signal: 1
    • cell activity and tumor cell activity: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37
    • cell activity and tumor killing: 1
    • cell activity and tumor microenvironment: 1, 2, 3, 4, 5, 6, 7
    • cell activity and tumor type: 1, 2
    • checkpoint inhibitor and immune evasion: 1, 2